v1
Phase II trial of trastuzumab followed by weekly paclitaxel/carboplatin as first-line treatment for patients with metastatic breast cancer.
- NobleID
- NI3P70W97R61S14
- Persistent link
- https://nobleid.org/ark:/48914/w1/20260515/683E2CDC
Type:Journal Article
0 views
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →